Meiya Haian Pharmaceutical Co., Ltd., established in January 2014 as a wholly-owned subsidiary of Hangzhou Meiya Pharmaceutical Co., specializes in the production of nucleotide series products. With a total investment exceeding 120 million RMB, the company operates a nearly 10, 000 square meter GMP-compliant facility and holds a Drug Production License. Their product range includes nucleosides, nucleotide monophosphates, diphosphates, triphosphates, cyclic nucleotides, polynucleotides, yeast nucleotides, and enzyme preparations, serving applications in medicine, dietary supplements, animal health, and diagnostic reagents.